Platypnoea-Orthodeoxia Syndrome in COVID-19
- PMID: 34790629
- PMCID: PMC8592651
- DOI: 10.12890/2021_002849
Platypnoea-Orthodeoxia Syndrome in COVID-19
Abstract
Platypnoea-orthodeoxia syndrome (POS) is a rare disorder and its pathophysiology has puzzled clinicians for years. Few cases of POS are described in COVID-19 patients in the literature, with a high variability of conditions related to the syndrome. In this article, we report the case of a patient admitted to our hospital for SARS-CoV-2 interstitial pneumonia, who developed POS during the hospitalization.
Learning points: Platypnoea-orthodeoxia syndrome (POS) is a possible and rare condition associated with SARS-CoV-2 pneumonia.A prompt diagnosis of POS is important in order to start careful and adequate oxygen supplementation.Clinical data on COVID-19 evolution in patients with POS and possible therapeutic and rehabilitative strategies are not available in the literature.
Keywords: COVID-19; Platypnoea-orthodeoxia syndrome; SARS-CoV-2.
© EFIM 2021.
Conflict of interest statement
Conflicts of Interests: The authors declare there are no competing interests.
Figures
References
-
- Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–793. - PubMed
-
- Cheng TO. Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interv. 1999;47(1):64–66. - PubMed
-
- Agrawal A, Palkar A, Talwar A. The multiple dimensions of platypnea-orthodeoxia syndrome: a review. Respir Med. 2017;129:31–38. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous